FOXO TECHNOLOGIES INC (FOXO)

US3514713052 - Common Stock

0.2751  0 (-1.61%)

After market: 0.279 +0 (+1.42%)

Fundamental Rating

1

FOXO gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 276 industry peers in the Software industry. FOXO has a bad profitability rating. Also its financial health evaluation is rather negative. FOXO does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

FOXO had negative earnings in the past year.
FOXO had a negative operating cash flow in the past year.

1.2 Ratios

FOXO has a Return On Assets of -2335.68%. This is amonst the worse of the industry: FOXO underperforms 97.45% of its industry peers.
Industry RankSector Rank
ROA -2335.68%
ROE N/A
ROIC N/A
ROA(3y)-162.62%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

FOXO has a Gross Margin of 37.78%. This is in the lower half of the industry: FOXO underperforms 75.18% of its industry peers.
The Profit Margin and Operating Margin are not available for FOXO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.78%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

FOXO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, FOXO has less shares outstanding
Compared to 1 year ago, FOXO has an improved debt to assets ratio.

2.2 Solvency

FOXO has an Altman-Z score of -121.43. This is a bad value and indicates that FOXO is not financially healthy and even has some risk of bankruptcy.
FOXO has a worse Altman-Z score (-121.43) than 95.26% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -121.43
ROIC/WACCN/A
WACC6.76%

2.3 Liquidity

FOXO has a Current Ratio of 0.19. This is a bad value and indicates that FOXO is not financially healthy enough and could expect problems in meeting its short term obligations.
FOXO has a worse Current ratio (0.19) than 97.81% of its industry peers.
FOXO has a Quick Ratio of 0.19. This is a bad value and indicates that FOXO is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of FOXO (0.11) is worse than 98.18% of its industry peers.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.11

1

3. Growth

3.1 Past

FOXO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -204.66%.
Looking at the last year, FOXO shows a very strong growth in Revenue. The Revenue has grown by 325.00%.
EPS 1Y (TTM)-204.66%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q78.01%
Revenue 1Y (TTM)325%
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2Q0%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for FOXO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for FOXO!.
Industry RankSector Rank
Dividend Yield N/A

FOXO TECHNOLOGIES INC

NYSEARCA:FOXO (5/3/2024, 7:04:01 PM)

After market: 0.279 +0 (+1.42%)

0.2751

0 (-1.61%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.46M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2335.68%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 37.78%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.19
Quick Ratio 0.11
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-204.66%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)325%
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y